Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Critical Reviews in Oncogenesis
|
August 4, 2021
Evaluation of NAMI-A Cytotoxic Effects toward Leukemia Cell Lines: A Slippery Ground Giving Misleading Messages
Alberta Bergamo, Gianni Sava
Molecules (Basel, Switzerland)
|
July 14, 2023
Pharmacological Modulation of Host Immunity with Hen Egg White Lysozyme (HEWL)-A Review
Alberta Bergamo, Gianni Sava
International Journal of Molecular Sciences
|
March 15, 2018
Chemical and Molecular Approach to Tumor Metastases
Alberta Bergamo, Gianni Sava
Molecules (Basel, Switzerland)
|
February 10, 2024
Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties
Alberta Bergamo, Gianni Sava
Dalton Transactions (Cambridge, England : 2003)
|
June 2, 2011
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo, Gianni Sava
Chemical Society Reviews
|
March 27, 2015
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Alberta Bergamo, Gianni Sava
Dalton Transactions (Cambridge, England : 2003)
|
July 5, 2011
Metal-based antitumour drugs in the post-genomic era: what comes next?
Gianni Sava, Alberta Bergamo, Paul J Dyson
Anti-Cancer Agents in Medicinal Chemistry
|
January 24, 2012
CDK1 hyperphosphorylation maintenance drives the time-course of G2-M cell cycle arrest after short treatment with NAMI-A in Kb cells
Alberta Bergamo, Riccarda Delfino, Claudia Casarsa, et al.
Current Topics in Medicinal Chemistry
|
December 8, 2004
Ruthenium antimetastatic agents
Enzo Alessio, Giovanni Mestroni, Alberta Bergamo, et al.
International Journal of Molecular Sciences
|
August 5, 2016
Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties
Anna Castellarin, Sonia Zorzet, Alberta Bergamo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Critical Reviews in Oncogenesis
|
August 4, 2021
Evaluation of NAMI-A Cytotoxic Effects toward Leukemia Cell Lines: A Slippery Ground Giving Misleading Messages
Alberta Bergamo, Gianni Sava
Molecules (Basel, Switzerland)
|
July 14, 2023
Pharmacological Modulation of Host Immunity with Hen Egg White Lysozyme (HEWL)-A Review
Alberta Bergamo, Gianni Sava
International Journal of Molecular Sciences
|
March 15, 2018
Chemical and Molecular Approach to Tumor Metastases
Alberta Bergamo, Gianni Sava
Molecules (Basel, Switzerland)
|
February 10, 2024
Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties
Alberta Bergamo, Gianni Sava
Dalton Transactions (Cambridge, England : 2003)
|
June 2, 2011
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo, Gianni Sava
Chemical Society Reviews
|
March 27, 2015
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Alberta Bergamo, Gianni Sava
Dalton Transactions (Cambridge, England : 2003)
|
July 5, 2011
Metal-based antitumour drugs in the post-genomic era: what comes next?
Gianni Sava, Alberta Bergamo, Paul J Dyson
Anti-Cancer Agents in Medicinal Chemistry
|
January 24, 2012
CDK1 hyperphosphorylation maintenance drives the time-course of G2-M cell cycle arrest after short treatment with NAMI-A in Kb cells
Alberta Bergamo, Riccarda Delfino, Claudia Casarsa, et al.
Current Topics in Medicinal Chemistry
|
December 8, 2004
Ruthenium antimetastatic agents
Enzo Alessio, Giovanni Mestroni, Alberta Bergamo, et al.
International Journal of Molecular Sciences
|
August 5, 2016
Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties
Anna Castellarin, Sonia Zorzet, Alberta Bergamo, et al.
Page
of 5